Evidence map›Paper›PMID 25626454›Full record

ArticleBMC bioinformatics2015

Quantitative analysis of differences in copy numbers using read depth obtained from PCR-enriched samples and controls.

Frank Reinecke, Ravi Vijaya Satya, John DiCarlo

Abstract readComparative Study
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Clinical and mutational profiles of adult medulloblastoma groups.Acta neuropathologica communications · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Frank ReineckeBioinformatics Assay Design & Analysis, QIAGEN GmbH, Max-Volmer-Straße 4, Hilden, 40724, Germany. frank.reinecke@qiagen.com.
Ravi Vijaya SatyaBioinformatics Assay Design & Analysis, QIAGEN Sciences Inc., 6951 Executive Way, Frederick MD, 21703, USA. ravi.vijayasatya@qiagen.com.
John DiCarloBioinformatics Assay Design & Analysis, QIAGEN Sciences Inc., 6951 Executive Way, Frederick MD, 21703, USA. john.dicarlo@qiagen.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNext-generation sequencing (NGS) is rapidly becoming common practice in clinical diagnostics and cancer research. In addition to the detection of single nucleotide variants (SNVs), information on copy number variants (CNVs) is of great interest. Several algorithms exist to detect CNVs by analyzing whole genome sequencing data or data from samples enriched by hybridization-capture. PCR-enriched amplicon-sequencing data have special characteristics that have been taken into account by only one publicly available algorithm so far.

resultsWe describe a new algorithm named quandico to detect copy number differences based on NGS data generated following PCR-enrichment. A weighted t-test statistic was applied to calculate probabilities (p-values) of copy number changes. We assessed the performance of the method using sequencing reads generated from reference DNA with known CNVs, and we were able to detect these variants with 98.6% sensitivity and 98.5% specificity which is significantly better than another recently described method for amplicon sequencing. The source code (R-package) of quandico is licensed under the GPLv3 and it is available at https://github.com/reineckef/quandico .

conclusionWe demonstrated that our new algorithm is suitable to call copy number changes using data from PCR-enriched samples with high sensitivity and specificity even for single copy differences.

Indexed as

AlgorithmsCase-Control StudiesDNA Copy Number VariationsHigh-Throughput Nucleotide SequencingHumansPolymerase Chain ReactionSensitivity and SpecificitySequence Analysis, DNA

Identifiers

PMID25626454
PMCPMC4384318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.